ConductScience.org, home

Paper32754259

EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.

Yin H and 10 others. Theranostics, 2020. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer. Papers, record 32754259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32754259

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
PubMed
Journal
Theranostics
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
3.22
iCite
Revised in PubMed
2021-07-19
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yin HHuilong
2Wang YYidi
3Wu YYe
4Zhang XXiang
5Zhang XXiaofang
6Liu JJun
7Wang TTing
8Fan JJing
9Sun JJianyong
10Yang AAngang
11Zhang RRui

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Enhancer of Zeste Homolog 2 ProteinMajor topic
MicroRNAsMajor topic
Protein-Lysine 6-OxidaseMajor topic
Animals
Cell Line, Tumor
Cell Movement
Cell Proliferation
Disease Progression
Epigenesis, Genetic
Female
Gene Expression Regulation, Neoplastic
Humans
MCF-7 Cells
Mice
Neoplasm Metastasis
Neoplasm Transplantation
Tumor Microenvironment

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131367244A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.Theranostics2019https://conductscience.org/library/papers/31367244PubMed
221115743Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.Mol Cancer Res2010https://conductscience.org/library/papers/21115743PubMed
322810810The rationale for targeting the LOX family in cancer.Nat Rev Cancer2012https://conductscience.org/library/papers/22810810PubMed
426290412Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis.Sci Transl Med2015https://conductscience.org/library/papers/26290412PubMed
526068592Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.Cell Death Differ2016https://conductscience.org/library/papers/26068592PubMed
611292829Molecular cloning and biological activity of a novel lysyl oxidase-related gene expressed in cartilage.J Biol Chem2001https://conductscience.org/library/papers/11292829PubMed
726756583Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.Int J Cancer2016https://conductscience.org/library/papers/26756583PubMed
830064438The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68.Mol Cancer2018https://conductscience.org/library/papers/30064438PubMed
930704479Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.Mol Cancer2019https://conductscience.org/library/papers/30704479PubMed
1026845405Targeting EZH2 in cancer.Nat Med2016https://conductscience.org/library/papers/26845405PubMed
1128060764LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer.Oncotarget2017https://conductscience.org/library/papers/28060764PubMed
1226171207miR-29b is an indicator of prognosis in breast cancer patients.Mol Clin Oncol2015https://conductscience.org/library/papers/26171207PubMed
1324607405Metastatic stem cells: sources, niches, and vital pathways.Cell Stem Cell2014https://conductscience.org/library/papers/24607405PubMed
1431410199Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer.Theranostics2019https://conductscience.org/library/papers/31410199PubMed
1525028505Molecular pathways: connecting fibrosis and solid tumor metastasis.Clin Cancer Res2014https://conductscience.org/library/papers/25028505PubMed
1627179746Role of the EZH2 histone methyltransferase as a therapeutic target in cancer.Pharmacol Ther2016https://conductscience.org/library/papers/27179746PubMed
1723539298EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.Breast Cancer Res Treat2013https://conductscience.org/library/papers/23539298PubMed
1818039110Tumor stroma and regulation of cancer development.Annu Rev Pathol2006https://conductscience.org/library/papers/18039110PubMed
1930993701Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.J Cell Physiol2019https://conductscience.org/library/papers/30993701PubMed
2023079660Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.Cancer Cell2012https://conductscience.org/library/papers/23079660PubMed

See all 54 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
42749970LOXL4: a key regulatory factor at the intersection of fibrosis and tumor progression.Hum Cell2026https://conductscience.org/library/papers/42749970PubMed
42348113Identification of Ferroptosis-related Genes Associated with the Prognosis of Hepatocellular Carcinoma.Cell Biochem Biophys2026https://conductscience.org/library/papers/42348113PubMed
39960560Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39960560PubMed
39247609Lysyl Oxidase (LOX) Family Proteins: Key Players in Breast Cancer Occurrence and Progression.J Cancer2024https://conductscience.org/library/papers/39247609PubMed
38774662H3K27Me3 abundance increases fibrogenesis during endothelial-to-mesenchymal transition via the silencing of microRNA-29c.Front Cardiovasc Med2024https://conductscience.org/library/papers/38774662PubMed
38737700The dual role of LOXL4 in the pathogenesis and development of human malignant tumors: a narrative review.Transl Cancer Res2024https://conductscience.org/library/papers/38737700PubMed
38534385EZH2-Myc Hallmark in Oncovirus/Cytomegalovirus Infections and Cytomegalovirus' Resemblance to Oncoviruses.Cells2024https://conductscience.org/library/papers/38534385PubMed
38339377Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment.Cancers (Basel)2024https://conductscience.org/library/papers/38339377PubMed
38333212Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures.Front Immunol2024https://conductscience.org/library/papers/38333212PubMed
38246995Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy.J Transl Med2024https://conductscience.org/library/papers/38246995PubMed
38008711EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/38008711PubMed
37958880Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.Int J Mol Sci2023https://conductscience.org/library/papers/37958880PubMed
37941557Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments.Front Oncol2023https://conductscience.org/library/papers/37941557PubMed
37904207miR-3195 suppresses the malignant progression of osteosarcoma cells via targeting SOX4.J Orthop Surg Res2023https://conductscience.org/library/papers/37904207PubMed
37814029The possibilities of LOXL4 as a prognostic marker for carcinomas.Amino Acids2023https://conductscience.org/library/papers/37814029PubMed
37803297Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner.BMC Cancer2023https://conductscience.org/library/papers/37803297PubMed
37626362Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma.BMC Med Genomics2023https://conductscience.org/library/papers/37626362PubMed
37373139Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/37373139PubMed
37217462Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37217462PubMed
37197500miR-183-5p regulates ECM and EMT to promote non-small cell lung cancer progression by targeting LOXL4.J Thorac Dis2023https://conductscience.org/library/papers/37197500PubMed

See all 52 cited byDownload CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ARG1383PubTator's text mininghttps://conductscience.org/library/genes/383NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
DICER123405PubTator's text mininghttps://conductscience.org/library/genes/23405NCBI Gene
EED8726PubTator's text mininghttps://conductscience.org/library/genes/8726NCBI Gene
ELN2006PubTator's text mininghttps://conductscience.org/library/genes/2006NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
EZH22146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
FN12335PubTator's text mininghttps://conductscience.org/library/genes/2335NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
LAMB23913PubTator's text mininghttps://conductscience.org/library/genes/3913NCBI Gene
LOX4015PubTator's text mininghttps://conductscience.org/library/genes/4015NCBI Gene
LOXL14016PubTator's text mininghttps://conductscience.org/library/genes/4016NCBI Gene
LOXL24017PubTator's text mininghttps://conductscience.org/library/genes/4017NCBI Gene
LOXL384695PubTator's text mininghttps://conductscience.org/library/genes/84695NCBI Gene
LOXL484171PubTator's text mininghttps://conductscience.org/library/genes/84171NCBI Gene
MIR143406935PubTator's text mininghttps://conductscience.org/library/genes/406935NCBI Gene
MIR29A407021PubTator's text mininghttps://conductscience.org/library/genes/407021NCBI Gene
MIR29B1407024PubTator's text mininghttps://conductscience.org/library/genes/407024NCBI Gene
MIR29B2407025PubTator's text mininghttps://conductscience.org/library/genes/407025NCBI Gene
MIR30D407033PubTator's text mininghttps://conductscience.org/library/genes/407033NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32754259

GET https://conductscience.org/api/papers/v1/32754259/references?page=2